Pulse Biosciences

Hayward, United States

Pulse Biosciences is a medical device company that engages in the research and development, and commercialization of CellFX system.

$13.3M raised

May 2026

Post-IPO Equity

Health Care Medical Medical Device Therapeutics

Top Investors

Robert Duggan Paul LaViolette Virginia Catalyst

Founder Contacts

30,000+ verified contacts

Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about Pulse Biosciences

How much funding has Pulse Biosciences raised?

Pulse Biosciences has raised $13.3M in total funding. The most recent round was Post-IPO Equity. The last funding was announced in May 2026.

Who are Pulse Biosciences's investors?

Pulse Biosciences's investors include Robert Duggan, Paul LaViolette, Virginia Catalyst.

Where is Pulse Biosciences headquartered?

Pulse Biosciences is headquartered in Hayward, United States.

What does Pulse Biosciences do?

Pulse Biosciences is a medical device company that engages in the research and development, and commercialization of CellFX system.

What stage is Pulse Biosciences at?

Pulse Biosciences is at the Post-IPO Equity stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated May 12, 2026.

MLA

"Pulse Biosciences — Funding & Investors." VCBacked, May 12, 2026, https://www.vcbacked.co/company/pulse-biosciences. Accessed July 2, 2026.

APA

VCBacked. (2026). Pulse Biosciences — Funding & Investors. Retrieved July 2, 2026, from https://www.vcbacked.co/company/pulse-biosciences

Wikipedia (cite web)

{{cite web |title=Pulse Biosciences — Funding & Investors |url=https://www.vcbacked.co/company/pulse-biosciences |website=VCBacked |access-date=July 2, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated May 12, 2026.

Similar Companies in Health Care

View all

Oryl Photonics

Lausanne

Allterum Therapeutics

Circl Brain Health Metrics

Victoria$354K

YLAH

Bern$589K